Top compounds associated with response to GRAMD4

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.26	4e-11
mRNA	selumetinib:vorinostat (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.23	4e-09
mRNA	serdemetan:SCH-529074 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.21	2e-08
mRNA	navitoclax:sorafenib (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.19	2e-07
mRNA	AZD6244	CTRPv2	pan-cancer	AAC	0.2	2e-07
mRNA	selumetinib:piperlongumine (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.19	3e-07
mRNA	PD318088	CTRPv2	pan-cancer	AAC	0.18	9e-07
mRNA	thapsigargin	gCSI	pan-cancer	AAC	-0.27	1e-06
mRNA	selumetinib:tretinoin (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.18	1e-06
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.18	1e-06

Download CSV